Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Have Faith in the Flu Shot

January 23, 2015 1:01 pm | by Chris DeFrancesco, University of Connecticut | News | Comments

The rate of effectiveness for this year’s vaccine has been disappointing, with at least half the states reporting widespread incidence of influenza. Read more...                 


A New Way to Test Brain Tumor Drugs

January 23, 2015 12:54 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

An Arizona hospital is testing medicines very early in development and never tried on brain tumors before. Read more....                        


Measles Outbreak Casts Spotlight on Anti-Vaccine Movement

January 23, 2015 12:49 pm | by Alicia Chang - AP Science Writer | News | Comments

A major measles outbreak traced to Disneyland has brought criticism down on the small but vocal movement among parents to opt out of vaccinations for their children. Read more...              


Progress in Diabetes Drug Delivery

January 23, 2015 9:23 am | by Rebecca Graham, Science Network WA | News | Comments

A DRUG therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery and prolong release. Read more...                 


Luoxis Establishes Initial European Distribution Network for Diagnostic System

January 23, 2015 9:15 am | by Luoxis | News | Comments

Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc.announced it has secured long-term agreements with European distributors Eurobio, Una Health Limited, and THP Medical, to offer Luoxis' RedoxSYS Diagnostic System to prominent academic and pharma-based research centers within their respective territories.  Read more...


Long-Awaited Ebola Vaccine Study Coming Soon in Liberia: U.S.

January 23, 2015 9:12 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Long-awaited studies of two possible Ebola vaccines are set to begin in West Africa in a couple of weeks, starting in Liberia, U.S. officials said. Read more...                                 


Identifying Potential Target for Epilepsy Treatment

January 23, 2015 9:07 am | by Imperial College | News | Comments

Epilepsy is a common and serious disease that affects around 50 million people worldwide. The mortality rate among people with epilepsy is two to three times higher than the general population. Read more...                           


Step Closer to Predicting Cancer Patients' Drug Toxicity

January 23, 2015 8:59 am | by University of Adelaide | News | Comments

Being able to predict that a patient will adversely react to a drug that's meant to be treating them is a key aim of personalized medicine, and could help to improve the patient's overall treatment. Read more...                  


Innovent Biologics Completes $100 Million Series C Financing

January 23, 2015 8:54 am | by Innovent Biologics | News | Comments

Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised$100 million in Series C financing. Legend Capital led the financing. Read more...


Why Protein Mutations Lead to Parkinson's

January 22, 2015 12:21 pm | by USCD | News | Comments

Researchers at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, have shown for the first time why protein mutations lead to the familial form of Parkinson's disease.                     


Axonal Death Pathway May Provide Neurodegenerative Drug Targets

January 22, 2015 12:17 pm | by Rockefeller Univ. | News | Comments

Axons connect neurons with each other to form the neural networks that underpin the vital functions of perception, motility, cognition, and memory. In many neurodegenerative disorders, from traumatic injury or toxic damage to diseases such as Alzheimer’s or Parkinson’s disease, axonal degeneration represents an essential pathological feature.


Colorectal Cancer Treatment Market Value to Hit $9.4B by 2020

January 22, 2015 12:01 pm | by GBI Research | News | Comments

The value of the Colorectal Cancer (CRC) therapeutics market will increase moderately, from $8.3 billion in 2013 to $9.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 1.8%, according to business intelligence provider GBI Research.


President Obama Announces Precision Medicine Initiative

January 22, 2015 11:59 am | by Ryan Bushey, Associate Editor | Articles | Comments

The President mentioned this project during the State of The Union, but did not provide specific details. Read more...                       


FDA Approves Novartis' Psoriasis Drug

January 22, 2015 11:44 am | by Novartis | News | Comments

Novartis announced the US Food and Drug Administration (FDA) has approved Cosentyx™ (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy.                           


Blood Vessels in Older Brains Break Down, Possibly Leading to Alzheimer's

January 22, 2015 11:27 am | by niversity of Southern California | News | Comments

University of Southern California (USC) neuroscientists may have unlocked another puzzle to preventing risks that can lead to Alzheimer's disease.                                                                 



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.